Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ABT-263 improves oral bioavailability and potency of Bcl-2 family protein inhibitors

April 22, 2008

Hedgehog pathway inhibitor shows potential benefits in cancer models

April 22, 2008

Modern Biosciences initiates phase I rimcazole trial in cancer

April 21, 2008

In vivo antitumor efficacy seen with Trop-2 antibody AR47A6.4.2

April 21, 2008

MethylGene initiates phase I clinical trial for MGCD-265 in solid tumors

April 18, 2008

Insert initiates phase II clinical trial with lead drug candidate IT-101 for ovarian cancer

April 18, 2008

FDA accepts Huya's IND-enabling nonclinical and clinical development plans for chidamide

April 18, 2008

XIAP knockdown allows cancer cell apoptosis with TRAIL in resistant cells

April 18, 2008

ArQule decides against further clinical testing of ARQ-171

April 17, 2008

Merck reports chemical structure of MK-0731

April 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...